Dr. Neil Notaroberto

Neil F. Notaroberto, MD, is Medical Director of the EyeCare 20/20 Louisiana and former Assistant Professor at the George Washington University Medical Center. Dr. Notaroberto is a fellowship trained ophthalmologist with expertise in retinal disease and surgery. His research in bioinformatics and healthcare information technology began at the Yale Medical Center and culminated with a Medical Informatics fellowship at the GWU Medical Center resulting in the first monthly live CME course over the Internet. Previous award winning projects included a surgical virtual reality simulator, computer based teaching modules and healthcare database systems. Current projects include digital analysis programs for determining stroke risk in patients by way of retinal vasculature measurements, medical database network distribution, and Internet based telemedicine projects for retinal disease. Dr. Notaroberto was trained in biology and computer science at Pacific University (Oregon) with experience in medical software and hardware. Graduate work in cardiovascular physiology was completed at Farleigh Dickenson University (New Jersey). Medical training was completed at George Washington University School of Medicine (Washington, D.C.) and Yale Medical Center (Connecticut). Ophthalmic training was completed at Tulane Medical Center (Louisiana). Retinal fellowship was completed at the Vitreoretinal Foundation/University of Tennessee Medical Center (Tennessee). Dr. Notaroberto has been honored by the American Medical Association and the Knights Templar Eye Foundation for his work in medicine and ocular disease. He currently is a consultant for Nuesoft Technologies (Atlanta, GA) and Centervue Technologies (Padova, Italy). Dr. Notaroberto’s most recent research in conjunction with the University of Padova in Italy, led to FDA approval for a new instrument to detect macular degeneration in adults before vision loss occurs. Currently his partners have collaborated to form a research division in the state of Louisiana to further advancements in treating ocular disease. The CLEVER Eye Institute can be found at http:// www.CleverEyeInstitute .com